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Identity 
Other names: CC3; TIP30; SDR44U1; FLJ26963 
HGNC (Hugo): HTATIP2 
Location: 11p15.1 
Note: HTATIP2, also called TIP30, is a transcriptional 




The human HTATIP2 gene has 6 exons that span more 
than 2.5 kb of genomic sequence located on 
chromosome 11p15.1. 
Transcription 
HTATIP2 has four types of transcripts with 1.5 kb, 1.4 
kb, 1.7 kb and 1.4 kb and they encode the same protin, 
242aa, as a result of alternative splicing. And a small 
type of HTATIP2 isoform is 0.78 kb composed of 2 




Genomic structure of published HTATIP2 alternatively spliced transcripts. Boxes indicate exons with coding regions in green. Red boxes 
indicate UTRs.
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Structure model of HTATIP2/TIP30. Serine-132, tyrosine-143 and lysine-147, which correspond to the catalytically active residues in 




HTATIP2 includes isoform a and isoform b, both of 
which contain 242aa, and isoform c, 131aa. HTATIP2 
can interact with the N-terminal trans-activation 
domain of HIV-tat directly as 30kDa Tat-interacting 
protein, to activate the HIV-1 promoter (Xiao et al., 
1998), and with an ERa-interacting coactivator CIA to 
repress the expression of c-myc (Jiang et al., 2004). It 
is a member of the short-chain 
dehydrogenases/reductases (SDR) family (Baker et al., 
2000) and have a cavity of NADPH binding site in its 
structure (El Omari et al., 2005). HTATIP2 has Ser/Th  
protein kinase activity, which can undergo 
autophosphorylation, and phosphorylates the 
heptapeptide repeats of the C-terminal domain of the 
largest RNA polymerase II subunit in a tat-dependent 
manner. HTATIP2 binds directly to the karyopherins of 
the importin beta family in a RanGTP-insensitive 
manner and associates with nucleoporins in vivo (King 
and Shtivelman, 2004). 
Expression 
HTATIP2 is an evolutionary conserved gene that is 
expressed ubiquitously in human tissues, while it is 
down-expressed in many tumors tissues, such as 
prostate, colon, liver, lung and breast cancers (Hewitt t 
al., 2000; Jiang et al., 2007; Lee et al., 2004; 
Varambally et al., 2002). 
Localisation 
HTATIP2 protein was found predominantly in the 
membrane and nuclear fractions but not in the 
particulate free cytoplasmic fraction (Whitman et al.,
2000). 
Function 
The HTATIP2 gene is a tumor susceptibility gene, 
which is associated with the suppression of metastasis 
in small cell lung cancer (SCLC) (Shtivelman, 1997), 
hepatocarcinoma (Ito et al., 2003). HTATIP2 interacts 
with an Estrogen Receptor alpha-interacting coactivtor 
CIA (coactivator independent of AF-2 function), to 
repress the expression of c-myc gene, and also 
associated with ets-1 to inhibit osteopontin 
transcription in human hepatocellular carcinoma (Zhao 
et al., 2008b). HTATIP2 forms a RanGTP-resistant 
complex with importins to inhibit nuclear import and 
induce apoptosis (King and Shtivelman, 2004). 
HTATIP2 also induces apoptosis under oxidative stres  
through stabilization of p53 mRNA (Zhao et al., 
2008a). 
Homology 
HTATIP2 encodes a protein whose sequence is highly 
conserved in evolution, with homologous genes being 
present in Caenorhabditis elegans, Saccharomyces 
cerevisiae, Escherichia coli (Whitman et al., 2000), 
Branchiostoma belcheri (Wang et al., 2008), and Mus 
musculus. 
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Mutations 
Note 
HTATIP2 mutant derived from hepatocellular 
carcinoma specimens promotes growth of HepG2 cells 
(Jiang et al., 2007). 
Somatic 
There are two types of HTATIP2 mutation, G134V and 
R106H, in hepatocellular carcinoma specimens (Jiang 
et al., 2007). 
 
The red amino acids are mutated into other one, as schematic 




HTATIP2 reported to be down-regulated in some kinds 
of cancers, such as lung cancer (NicAmhlaoibh and 
Shtivelman, 2001), hepato-cellular carcinoma (Zhao et 
al., 2008), gastric cancer (Li et al., 2009), prostate 
cancer (Zhang et al., 2008), breast carcinoma (Zhang et 
al., 2005; Zhao et al., 2007). 
Multiple sclerosis (MS) 
Disease 
Oligodendrocyte precursor cells (OPCs) presist nearthe 
demyelinated axons arising in MS but inefficiently 
differentiate into oligodendrocytes and remyelinate 
these axons. Abnormal expression of HTATIP2, a 
direct inhibitor of Importin, is observed in these OPCs. 
Overexpression of HTATIP2 in a rat OPC cell line 
resulted in cytoplasmic entrapment of NICD and arrest 
of differentiation upon stimulation with Contactin- Fc. 
References 
Shtivelman E. A link between metastasis and resistance to 
apoptosis of variant small cell lung carcinoma. Oncogene. 
1997 May 8;14(18):2167-73 
Xiao H, Tao Y, Greenblatt J, Roeder RG. A cofactor, TIP30, 
specifically enhances HIV-1 Tat-activated transcription. Proc 
Natl Acad Sci U S A. 1998 Mar 3;95(5):2146-51 
Baker ME, Yan L, Pear MR. Three-dimensional model of 
human TIP30, a coactivator for HIV-1 Tat-activated 
transcription, and CC3, a protein associated with metastasis 
suppression. Cell Mol Life Sci. 2000 May;57(5):851-8 
Hewitt RE, Brown KE, Corcoran M, Stetler-Stevenson WG. 
Increased expression of tissue inhibitor of metalloproteinases 
type 1 (TIMP-1) in a more tumourigenic colon cancer cell line. 
J Pathol. 2000 Dec;192(4):455-9 
Whitman S, Wang X, Shalaby R, Shtivelman E. Alternatively 
spliced products CC3 and TC3 have opposing effects on 
apoptosis. Mol Cell Biol. 2000 Jan;20(2):583-93 
NicAmhlaoibh R, Shtivelman E. Metastasis suppressor CC3 
inhibits angiogenic properties of tumor cells in vitro.  
 
Oncogene. 2001 Jan 11;20(2):270-5 
Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, 
Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, 
Otte AP, Rubin MA, Chinnaiyan AM. The polycomb group 
protein EZH2 is involved in progression of prostate cancer. 
Nature. 2002 Oct 10;419(6907):624-9 
Ito M, Jiang C, Krumm K, Zhang X, Pecha J, Zhao J, Guo Y, 
Roeder RG, Xiao H. TIP30 deficiency increases susceptibility 
to tumorigenesis. Cancer Res. 2003 Dec 15;63(24):8763-7 
Jiang C, Ito M, Piening V, Bruck K, Roeder RG, Xiao H. TIP30 
interacts with an estrogen receptor alpha-interacting 
coactivator CIA and regulates c-myc transcription. J Biol 
Chem. 2004 Jun 25;279(26):27781-9 
King FW, Shtivelman E. Inhibition of nuclear import by the 
proapoptotic protein CC3. Mol Cell Biol. 2004 
Aug;24(16):7091-101 
Lee LW, Zhang DH, Lee KT, Koay ES, Hewitt RE. CC3/TIP30 
expression was strongly associated with HER-2/NEU status in 
breast cancer. Ann Acad Med Singapore. 2004 Sep;33(5 
Suppl):S30-2 
El Omari K, Bird LE, Nichols CE, Ren J, Stammers DK. Crystal 
structure of CC3 (TIP30): implications for its role as a tumor 
suppressor. J Biol Chem. 2005 May 6;280(18):18229-36 
Zhang DH, Wong LL, Tai LK, Koay ES, Hewitt RE. 
Overexpression of CC3/TIP30 is associated with HER-2/neu 
status in breast cancer. J Cancer Res Clin Oncol. 2005 
Sep;131(9):603-8 
Jiang C, Pecha J, Hoshino I, Ankrapp D, Xiao H. TIP30 mutant 
derived from hepatocellular carcinoma specimens promotes 
growth of HepG2 cells through up-regulation of N-cadherin. 
Cancer Res. 2007 Apr 15;67(8):3574-82 
Zhao J, Ni H, Ma Y, Dong L, Dai J, Zhao F, Yan X, Lu B, Xu H, 
Guo Y. TIP30/CC3 expression in breast carcinoma: relation to 
metastasis, clinicopathologic parameters, and P53 expression. 
Hum Pathol. 2007 Feb;38(2):293-8 
Lu B, Ma Y, Wu G, Tong X, Guo H, Liang A, Cong W, Liu C, 
Wang H, Wu M, Zhao J, Guo Y. Methylation of Tip30 promoter 
is associated with poor prognosis in human hepatocellular 
carcinoma. Clin Cancer Res. 2008 Nov 15;14(22):7405-12 
Wang S, Zhao B, Zhang S, Ji H. Cloning, expression, 
purification, and characterization of AmphiTip30, a member of 
short-chain dehydrogenases/reductases family from the 
amphioxus Branchiostoma belcheri tsingtauense. Protein Expr 
Purif. 2008 Jan;57(1):63-71 
Zhang H, Zhang Y, Duan HO, Kirley SD, Lin SX, McDougal 
WS, Xiao H, Wu CL. TIP30 is associated with progression and 
metastasis of prostate cancer. Int J Cancer. 2008 Aug 
15;123(4):810-6 






Atlas Genet Cytogenet Oncol Haematol. 2010; 14(2) 140 
Zhao J, Chen J, Lu B, Dong L, Wang H, Bi C, Wu G, Guo H, 
Wu M, Guo Y. TIP30 induces apoptosis under oxidative stress 
through stabilization of p53 messenger RNA in human 
hepatocellular carcinoma. Cancer Res. 2008 Jun 
1;68(11):4133-41 
Zhao J, Lu B, Xu H, Tong X, Wu G, Zhang X, Liang A, Cong 
W, Dai J, Wang H, Wu M, Guo Y. Thirty-kilodalton Tat-
interacting protein suppresses tumor metastasis by inhibition of 
osteopontin transcription in human hepatocellular carcinoma. 
Hepatology. 2008 Jul;48(1):265-75 
Li X, Zhang Y, Cao S, Chen X, Lu Y, Jin H, Sun S, Chen B, Liu 
J, Ding J, Wu K, Fan D. Reduction of TIP30 correlates with 
poor prognosis of gastric cancer patients and its restoration 
drastically inhibits tumor growth and metastasis. Int J Cancer. 
2009 Feb 1;124(3):713-21 
Nakahara J, Kanekura K, Nawa M, Aiso S, Suzuki N. Abnormal 
expression of TIP30 and arrested nucleocytoplasmic transport 
within oligodendrocyte precursor cells in multiple sclerosis. J 
Clin Invest. 2009 Jan;119(1):169-81 
This article should be referenced as such: 
Zhao J. HTATIP2 (HIV-1 Tat interactive protein 2, 30kDa). 
Atlas Genet Cytogenet Oncol Haematol. 2010; 14(2):137-140. 
